The BM cells were immediately treated with 1 mmol/l l-SOS, the xCT blocker, after being isolated from the BLM-challenged mice at day 14 to test the importance of elevated xCT on Glu release during BLM-induced PF. The gene discussed is SLC7A11; the disease is Bloom syndrome.